CN114404507A - 一种缓解骨伤疼痛的外敷药水及其制备方法 - Google Patents
一种缓解骨伤疼痛的外敷药水及其制备方法 Download PDFInfo
- Publication number
- CN114404507A CN114404507A CN202210251200.9A CN202210251200A CN114404507A CN 114404507 A CN114404507 A CN 114404507A CN 202210251200 A CN202210251200 A CN 202210251200A CN 114404507 A CN114404507 A CN 114404507A
- Authority
- CN
- China
- Prior art keywords
- parts
- liquid medicine
- bone injury
- pain
- relieving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 208000002193 Pain Diseases 0.000 title claims abstract description 65
- 230000036407 pain Effects 0.000 title claims abstract description 63
- 239000007788 liquid Substances 0.000 title claims abstract description 50
- 206010061363 Skeletal injury Diseases 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 56
- 239000000843 powder Substances 0.000 claims abstract description 32
- 239000002904 solvent Substances 0.000 claims abstract description 28
- 238000002791 soaking Methods 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 23
- 239000004863 Frankincense Substances 0.000 claims abstract description 19
- 239000006228 supernatant Substances 0.000 claims abstract description 13
- 238000000227 grinding Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 22
- 229940116229 borneol Drugs 0.000 claims description 22
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 22
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 22
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 20
- 244000018633 Prunus armeniaca Species 0.000 claims description 20
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 20
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 20
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 20
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 19
- 244000020518 Carthamus tinctorius Species 0.000 claims description 19
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 18
- 240000007551 Boswellia serrata Species 0.000 claims description 18
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 18
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 18
- 244000018716 Impatiens biflora Species 0.000 claims description 18
- 235000015912 Impatiens biflora Nutrition 0.000 claims description 18
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 18
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 18
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims description 18
- 239000009136 dragon's blood Substances 0.000 claims description 18
- 244000144730 Amygdalus persica Species 0.000 claims description 17
- 240000007311 Commiphora myrrha Species 0.000 claims description 17
- 241000195955 Equisetum hyemale Species 0.000 claims description 17
- 241000195954 Lycopodium clavatum Species 0.000 claims description 17
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 16
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 16
- 240000001851 Artemisia dracunculus Species 0.000 claims description 16
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 16
- 239000001138 artemisia absinthium Substances 0.000 claims description 16
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 16
- 240000004824 Trimezia steyermarkii Species 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- 241000283966 Pholidota <mammal> Species 0.000 claims description 9
- 241000212322 Levisticum officinale Species 0.000 claims description 8
- 239000001645 levisticum officinale Substances 0.000 claims description 8
- 241000244365 Ligusticum sinense Species 0.000 claims description 5
- 241000112528 Ligusticum striatum Species 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 230000035876 healing Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 210000002449 bone cell Anatomy 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000628997 Flos Species 0.000 abstract 2
- 241000717739 Boswellia sacra Species 0.000 abstract 1
- 241000283956 Manis Species 0.000 abstract 1
- 241001057584 Myrrha Species 0.000 abstract 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 abstract 1
- 230000009982 effect on human Effects 0.000 abstract 1
- 239000009286 sanguis draxonis Substances 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 206010042674 Swelling Diseases 0.000 description 15
- 230000008961 swelling Effects 0.000 description 15
- 208000010392 Bone Fractures Diseases 0.000 description 12
- 206010017076 Fracture Diseases 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 208000014674 injury Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000002040 relaxant effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 239000002344 surface layer Substances 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000003857 wrist joint Anatomy 0.000 description 3
- 241000123844 Artemisia anomala Species 0.000 description 2
- 235000014290 Artemisia anomala Nutrition 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000085625 Equisetum Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000004821 effect on bone Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000005739 manihot Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960001929 meloxicam Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种缓解骨伤疼痛的外敷药水及其制备方法,属于中药组合物技术领域。该外敷药水的制备方法为:将刘寄奴、红花、透骨草、冰片、乳香、伸筋草、血竭、川穹、桃仁、甲珠片、五加皮、杏花、木贼、没药和松香分别研磨成粉末,混合均匀之后置于乙醇溶剂中浸泡,取上清液即得所述缓解骨伤疼痛的外敷药水。该外敷药水对人体无毒副作用,可以长期使用,不会产生耐药性,同时可以有效促进骨伤部位的骨细胞大量繁殖,促进骨伤愈合,消炎镇痛,活血化瘀,可明显缓解患者的骨伤疼痛,制备方法简单,药水见效快,适合各年龄阶段的人群,具有广阔的市场应用前景。
Description
技术领域
本发明涉及一种缓解骨伤疼痛的外敷药水及其制备方法,属于中药组合物技术领域。
背景技术
骨折骨裂是目前常见的一种临床症状,对骨折骨裂的治疗仅仅是局限于固定、复位,然后进行长期静养,等待骨体愈合恢复。骨伤后,骨折的断端会发生出血,导致局部的软组织充血水肿,刺激周围的痛觉神经后,就会引起疼痛的症状。骨骼受到暴力作用后会发生不同程度的损伤,周围软组织也会受到一定程度的损伤,暴力作用于人体局部,本身就会产生疼痛的症状,再加上软组织充血水肿后刺激周围神经末梢,疼痛会更加明显。
骨伤后疼痛要早期的进行止痛的治疗,止痛治疗包括药物治疗以及非药物治疗。第一,非药物治疗:骨伤后由于骨折处刺激了神经,或者是骨伤之后,骨膜的周围的神经受到了损伤而出现疼痛,这时要在早期对于骨伤处进行制动,能够防止骨折对于骨膜的刺激而进一步使疼痛加重,同时在固定之后要抬高患肢,促进血液的回流,但是该方法存在见效慢,并不适合人体所有部位。第二,药物治疗:在早期要口服止痛的药,比如口服消炎止痛的药物美洛昔康、塞来昔布,还可以口服氨酚待因片进行治疗,但是该方法会使患者产生耐药性,并不适合长期服用;另外,也有使用外用的中药制剂配方止痛贴剂,但均存在病程长、恢复慢、痛苦大的问题,治疗效果均不理想。
所以,本发明针对骨折骨裂之后导致的骨伤疼痛的问题,提出了一种可以快速缓解骨伤疼痛的外用药物组合物。
发明内容
为了解决上述技术问题,本发明提供了一种缓解骨伤疼痛的外敷药水及其制备方法,各原料相互配合,协同增效,使制备的药水具有消肿止痛,舒筋活络,活血祛瘀,抗炎抗菌的作用,可以有效促进骨伤组织的愈合,加快血液循环,起到快速缓解骨伤疼痛的效果。
为实现上述目的,本发明提供了如下方案:
本发明提供了一种缓解骨伤疼痛的外敷药水,按重量份数计,包括以下原料:刘寄奴30~50份、红花20~60份、透骨草20~40份、冰片10~35份、乳香10~20份、伸筋草5~20份、血竭20~50份、川穹5~15份、桃仁20~50份、甲珠片10~20份、五加皮24~36份、杏花20~40份、木贼10~20份、没药15~25份和松香25~45份。
进一步地,按重量份数计,包括以下原料:刘寄奴36~48份、红花22~52份、透骨草25~40份、冰片16~30份、乳香11~18份、伸筋草9~15份、血竭26~38份、川穹5~10份、桃仁30~48份、甲珠片10~16份、五加皮25~35份、杏花25~35份、木贼12~20份、没药20~25份和松香30~40份。
进一步地,按重量份数计,包括以下原料:刘寄奴40份、红花48份、透骨草32份、冰片19份、乳香15份、伸筋草10份、血竭32份、川穹6份、桃仁33份、甲珠片12份、五加皮30份、杏花28份、木贼15份、没药23份和松香38份。
本发明还提供了一种上述的缓解骨伤疼痛的外敷药水的制备方法,包括以下步骤:
按重量份数称取各原料,将所述刘寄奴、红花、透骨草、冰片、乳香、伸筋草、血竭、川穹、桃仁、甲珠片、五加皮、杏花、木贼、没药和松香分别研磨成粉末,混合均匀之后置于乙醇溶剂中浸泡,取上清液即得所述缓解骨伤疼痛的外敷药水。
进一步地,所述研磨的目数为100~200目。
进一步地,将中药粉末混合均匀之后置于质量浓度为50%的乙醇溶剂中进行第一次浸泡,之后取滤渣置于质量浓度为75%的乙醇溶剂中进行第二次浸泡,合并两次上清液即为所述缓解骨伤疼痛的外敷药水。
进一步地,所述中药粉末与质量浓度为50%的乙醇溶剂的料液比为1g:(20~30)ml,所述第一次浸泡的时间为5~7天。
进一步地,所述中药粉末与质量浓度为75%的乙醇溶剂的料液比为1g:(8~10)ml,所述第二次浸泡的时间为2~3天。
本发明的缓解骨伤疼痛的外敷药水在缓解骨伤疼痛时使用方法为,将所述外敷药水直接喷涂于骨伤疼痛的皮肤外表层,每日三次。
具体的各个药物成分的药理如下:
刘寄奴:苦,性温。用于疗伤止血,破血通经,消食化积,醒脾开胃、敛疮消肿、治经闭症瘕,胸腹胀痛,产后血瘀,跌打损伤,金疮出血,痈毒焮肿。
红花:味辛,性温。活血通经、散瘀止痛。
透骨草:味辛,性温。活血化瘀、利尿解毒、通经透骨、舒筋活络、活血止痛、解毒化疹。
冰片:辛、苦,微寒;通诸窍,散郁火,去翳明目,消肿止痛。
乳香:味辛、苦,性温。活血行气止痛,消肿生肌。
伸筋草:味苦,性温,入肝经。主治功效:祛风散寒,除湿消肿,舒筋活络。用于风寒湿痹,筋脉拘挛疼痈。外用治跌打扭伤肿痛。
血竭:味甘、咸,性平。入肝经。跌打损伤,瘀滞心腹疼痛。
川穹:辛,温;活血祛瘀,行气开郁,祛风止痛。
桃仁:味甘、咸,性平。润肠通便,活血祛瘀。
甲珠片:通经活络,消炎杀菌,消肿止痛。
五加皮:味辛、苦,性温。用于治疗风寒湿廯,腰膝疼痛、筋骨拘挛,消水肿、肾虚寒、伤精损髓,腰痛。
杏花:补中益气,祛风通络。
木贼:甘、苦、平,有名节骨草,止血,抗菌、抗病毒,抑制血小板聚集。
没药:苦、辛、平。消肿生肌,理气止疼,活血祛瘀。
松香:味苦、甘,性温。祛风燥湿,排脓拔毒,生肌止痛。
本发明公开了以下技术效果:
1)本发明的外敷药水对骨伤疼痛具有较好的缓解作用,通过以刘寄奴、红花、透骨草、冰片、乳香、伸筋草、血竭、川穹、桃仁、甲珠片、五加皮、杏花、木贼、没药和松香作为原料,一方面,对人体无毒副作用,可以长期使用,不会产生耐药性,另一方面,该外敷药水可以有效促进骨伤部位的骨细胞大量繁殖,促进骨伤愈合,消炎镇痛,活血化瘀,可明显缓解患者的骨伤疼痛。
2)本发明的外敷药水,添加了松香,利用松香的溶解性将其溶解于乙醇溶剂中,喷涂于患者皮肤表层可以快速成膜,减少药水中有效成分的挥发,另外,该外敷药水中还添加了杏花和红花,杏花具有糯米的香味,沁人心脾,可以有效降低其他中药提取物的刺鼻气味,而红花的乙醇提取物为橙红色,可以使药水具备一定的颜色,当喷涂于患者皮肤表层可以直观的辨别出作用的范围,减少不必要的浪费;除此之外,采用刘寄奴、透骨草、冰片、乳香、伸筋草、血竭、川穹、甲珠片、五加皮、木贼和没药等原料相互配合,协同增效,使制备的药水具有消肿止痛,舒筋活络,活血祛瘀,抗炎抗菌的作用功效,可以有效促进骨伤组织的愈合,加快血液循环,起到快速缓解骨伤疼痛的效果。
3)本发明将各中药材原料粉碎并多次浸泡,使有效成分充分溶解,制备方法简单,药水见效快,适合各年龄阶段的人群,具有广阔的市场应用前景。
具体实施方式
现详细说明本发明的多种示例性实施方式,该详细说明不应认为是对本发明的限制,而应理解为是对本发明的某些方面、特性和实施方案的更详细的描述。
应理解本发明中所述的术语仅仅是为描述特别的实施方式,并非用于限制本发明。另外,对于本发明中的数值范围,应理解为还具体公开了该范围的上限和下限之间的每个中间值。在任何陈述值或陈述范围内的中间值,以及任何其他陈述值或在所述范围内的中间值之间的每个较小的范围也包括在本发明内。这些较小范围的上限和下限可独立地包括或排除在范围内。
除非另有说明,否则本文使用的所有技术和科学术语具有本发明所述领域的常规技术人员通常理解的相同含义。虽然本发明仅描述了优选的方法和材料,但是在本发明的实施或测试中也可以使用与本文所述相似或等同的任何方法和材料。本说明书中提到的所有文献通过引用并入,用以公开和描述与所述文献相关的方法和/或材料。在与任何并入的文献冲突时,以本说明书的内容为准。
在不背离本发明的范围或精神的情况下,可对本发明说明书的具体实施方式做多种改进和变化,这对本领域技术人员而言是显而易见的。由本发明的说明书得到的其他实施方式对技术人员而言是显而易见得的。本发明说明书和实施例仅是示例性的。
关于本文中所使用的“包含”、“包括”、“具有”、“含有”等等,均为开放性的用语,即意指包含但不限于。
本发明实施例所用刘寄奴、红花、透骨草、冰片、乳香、伸筋草、血竭、川穹、桃仁、甲珠片、五加皮、杏花、木贼、没药、松香、质量浓度为75%和50%的乙醇溶剂均为通过市售购买得到。
本发明实施例研磨所用的机器为中草药磨粉机,生产厂家为山东维诺医药设备制造有限公司。
以下通过实施例对本发明的技术方案做进一步说明。
实施例1
分别称取刘寄奴40g、红花48g、透骨草32g、冰片19g、乳香15g、伸筋草10g、血竭32g、川穹6g、桃仁33g、甲珠片12g、五加皮30g、杏花28g、木贼15g、没药23g和松香38g,之后分别研磨成目数为150目的粉末,混合均匀成中药粉末之后置于7620ml质量浓度为50%的乙醇溶剂中浸泡6天,之后取出滤渣置于3810ml质量浓度为75%的乙醇溶剂中浸泡2天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
实施例2
分别称取刘寄奴40g、红花48g、透骨草32g、冰片19g、乳香15g、伸筋草10g、血竭32g、川穹6g、桃仁33g、甲珠片12g、五加皮30g、杏花28g、木贼15g、没药23g和松香38g,之后分别研磨成目数为100目的粉末,混合均匀成中药粉末之后置于11430ml质量浓度为50%的乙醇溶剂中浸泡7天,之后取出滤渣置于3048ml质量浓度为75%的乙醇溶剂中浸泡3天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
实施例3
分别称取刘寄奴50g、红花20g、透骨草40g、冰片35g、乳香10g、伸筋草20g、血竭50g、川穹5g、桃仁50g、甲珠片20g、五加皮36g、杏花40g、木贼20g、没药25g和松香25g,之后分别研磨成目数为200目的粉末,混合均匀成中药粉末之后置于8920ml质量浓度为50%的乙醇溶剂中浸泡7天,之后取出滤渣置于4460ml质量浓度为75%的乙醇溶剂中浸泡2天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
实施例4
分别称取刘寄奴36g、红花22g、透骨草25g、冰片16g、乳香18g、伸筋草9g、血竭38g、川穹10g、桃仁48g、甲珠片16g、五加皮25g、杏花35g、木贼12g、没药25g和松香40g,之后分别研磨成目数为100目的粉末,混合均匀成中药粉末之后置于7500ml质量浓度为50%的乙醇溶剂中浸泡5天,之后取出滤渣置于3000ml质量浓度为75%的乙醇溶剂中浸泡2天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
实施例5
分别称取刘寄奴30g、红花60g、透骨草20g、冰片10g、乳香20g、伸筋草5g、血竭20g、川穹5g、桃仁20g、甲珠片10g、五加皮24g、杏花20g、木贼10g、没药15g和松香45g,之后分别研磨成目数为150目的粉末,混合均匀成中药粉末之后置于9420ml质量浓度为50%的乙醇溶剂中浸泡6天,之后取出滤渣置于3140ml质量浓度为75%的乙醇溶剂中浸泡3天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
对比例1
分别称取刘寄奴60g、红花15g、透骨草30g、冰片45g、乳香30g、伸筋草3g、血竭15g、川穹25g、桃仁15g、甲珠片8g、五加皮12g、杏花45g、木贼30g、没药30g和松香50g,之后分别研磨成目数为150目的粉末,混合均匀成中药粉末之后置于8260ml质量浓度为50%的乙醇溶剂中浸泡6天,之后取出滤渣置于4130ml质量浓度为75%的乙醇溶剂中浸泡2天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
对比例2
分别称取刘寄奴40g、透骨草32g、冰片19g、乳香15g、血竭32g、川穹6g、桃仁33g、甲珠片12g、五加皮30g、杏花28g、木贼15g、没药23g,之后分别研磨成目数为150目的粉末,混合均匀成中药粉末之后置于5700ml质量浓度为50%的乙醇溶剂中浸泡6天,之后取出滤渣置于2850ml质量浓度为75%的乙醇溶剂中浸泡2天,合并两次上清液即得缓解骨伤疼痛的外敷药水。
对比例3
同实施例1,区别仅在于,混合均匀成中药粉末之后置于7620ml质量浓度为50%的乙醇溶剂中浸泡6天,取上清液即得缓解骨伤疼痛的外敷药水。
对比例4
奇正消痛贴膏。
一、临床效果检测
征集450名确诊骨折并经固定处理的患者,年龄在18~65岁,随机分为9组,每组50人,各组病例的病情、年龄、性别均无显著差异。
治疗方法:前8组分别喷涂本发明实施例1~5与对比例1~3制备的外敷药水,每天早中晚各一次,最后一组贴对比例4的奇正消痛贴膏,每贴贴24小时,一周一疗程,治疗三个疗程。
治疗标准:有效:肿胀疼痛感完全消失,不再重复,骨折部位可以缓慢移动;无效:症状无变化。
治疗结果见表1。
表1各组治疗效果
由表1的数据可以看出,使用本发明实施例制备得到的外敷药水可以在较短时间内达到缓解疼痛的效果,并且在三个疗程内即可使疼痛感完全消失,不再复发,较对比例的治疗效果和速度均有明显提高。
典型病例
刘某,男,26岁,在打篮球过程中扭伤右踝关节,造成右踝关节肿胀疼痛,经医院检查,无骨折移位,喷涂本发明的外敷药水1周后肿胀疼痛感消失,2周后可自由活动,痊愈。
薛某某,女,48岁,在卫生间滑倒,造成左腿胫骨骨折,去医院进行骨折处理后,左小腿红肿疼痛,不能自主活动,喷涂本发明的外敷药水9天后肿胀疼痛感缓解,皮肤由红色变为正常,3周后小腿无胀痛感。
赵某,男,60岁,在买菜途中不慎摔倒,造成左手腕摔伤错位,次日左手腕关节处红肿疼痛,腕关节不能旋转,喷涂本发明的外敷药水6天后红肿消失,2周后腕关节可自由旋转,疼痛感消失。
以上所述的实施例仅是对本发明的优选方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案做出的各种变形和改进,均应落入本发明权利要求书确定的保护范围内。
Claims (8)
1.一种缓解骨伤疼痛的外敷药水,其特征在于,按重量份数计,包括以下原料:刘寄奴30~50份、红花20~60份、透骨草20~40份、冰片10~35份、乳香10~20份、伸筋草5~20份、血竭20~50份、川穹5~15份、桃仁20~50份、甲珠片10~20份、五加皮24~36份、杏花20~40份、木贼10~20份、没药15~25份和松香25~45份。
2.根据权利要求1所述的缓解骨伤疼痛的外敷药水,其特征在于,按重量份数计,包括以下原料:刘寄奴36~48份、红花22~52份、透骨草25~40份、冰片16~30份、乳香11~18份、伸筋草9~15份、血竭26~38份、川穹5~10份、桃仁30~48份、甲珠片10~16份、五加皮25~35份、杏花25~35份、木贼12~20份、没药20~25份和松香30~40份。
3.根据权利要求1所述的缓解骨伤疼痛的外敷药水,其特征在于,按重量份数计,包括以下原料:刘寄奴40份、红花48份、透骨草32份、冰片19份、乳香15份、伸筋草10份、血竭32份、川穹6份、桃仁33份、甲珠片12份、五加皮30份、杏花28份、木贼15份、没药23份和松香38份。
4.一种权利要求1~3任一项所述的缓解骨伤疼痛的外敷药水的制备方法,其特征在于,包括以下步骤:
按重量份数称取各原料,将所述刘寄奴、红花、透骨草、冰片、乳香、伸筋草、血竭、川穹、桃仁、甲珠片、五加皮、杏花、木贼、没药和松香分别研磨成粉末,混合均匀之后置于乙醇溶剂中浸泡,取上清液即得所述缓解骨伤疼痛的外敷药水。
5.根据权利要求4所述的制备方法,其特征在于,所述研磨的目数为100~200目。
6.根据权利要求4所述的制备方法,其特征在于,将中药粉末混合均匀之后置于质量浓度为50%的乙醇溶剂中进行第一次浸泡,之后取滤渣置于质量浓度为75%的乙醇溶剂中进行第二次浸泡,合并两次上清液即为所述缓解骨伤疼痛的外敷药水。
7.根据权利要求6所述的制备方法,其特征在于,所述中药粉末与质量浓度为50%的乙醇溶剂的料液比为1g:(20~30)ml,所述第一次浸泡的时间为5~7天。
8.根据权利要求6所述的制备方法,其特征在于,所述中药粉末与质量浓度为75%的乙醇溶剂的料液比为1g:(8~10)ml,所述第二次浸泡的时间为2~3天。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210251200.9A CN114404507A (zh) | 2022-03-15 | 2022-03-15 | 一种缓解骨伤疼痛的外敷药水及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210251200.9A CN114404507A (zh) | 2022-03-15 | 2022-03-15 | 一种缓解骨伤疼痛的外敷药水及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114404507A true CN114404507A (zh) | 2022-04-29 |
Family
ID=81263311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210251200.9A Pending CN114404507A (zh) | 2022-03-15 | 2022-03-15 | 一种缓解骨伤疼痛的外敷药水及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114404507A (zh) |
-
2022
- 2022-03-15 CN CN202210251200.9A patent/CN114404507A/zh active Pending
Non-Patent Citations (1)
Title |
---|
刘淑娟: "舒筋活血汤熏洗治疗软组织损伤40例观察", 《甘肃中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102895365B (zh) | 一种治疗骨损伤及骨科炎症的外用药膏 | |
CN108175795A (zh) | 一种膏药 | |
CN112915173A (zh) | 一种治疗骨科类疾病的中药组合物、制剂及制备方法和应用 | |
CN112057585A (zh) | 含有多种精油治疗颈肩腰腿痛的贴剂配方及其制备方法 | |
CN101066307B (zh) | 无疤痕烧伤药粉及其制备方法 | |
CN103784550B (zh) | 用于消肿止痛的中药组合物及其制剂 | |
CN105106796A (zh) | 一种治疗骨折的中药组合物及其制备方法 | |
CN101554449B (zh) | 一种治疗外伤的中药 | |
CN114306458A (zh) | 一种治疗骨质增生的中药组合物及其制备方法 | |
CN114404507A (zh) | 一种缓解骨伤疼痛的外敷药水及其制备方法 | |
CN102406792B (zh) | 一种快速促进骨折愈合的药物组合物 | |
CN1315516C (zh) | 一种治疗风湿病的药物 | |
CN114129698B (zh) | 一种治疗腱鞘炎的外用中药 | |
CN102697928B (zh) | 一种治疗跌打损伤的药物组合物的制备方法 | |
CN105560537A (zh) | 一种治疗骨性关节病的药物组合物及其制备方法 | |
CN105267411B (zh) | 一种治疗骨折的药物组合物 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN105327290A (zh) | 一种治疗糖尿病坏疽的外用中药及其制备方法 | |
CN105617214A (zh) | 一种治疗疥疮的中药组合物 | |
CN104173593A (zh) | 一种活血止痛的中药组合物及其制备方法 | |
CN113288948A (zh) | 一种用于缓解肱骨外上髁炎的药物 | |
CN116712498A (zh) | 中药原料组合物、药物组合物及其应用 | |
CN104840840A (zh) | 治疗跟痛症的中药外洗剂及制法 | |
CN104257931A (zh) | 骨科用跌打损伤外敷贴剂及制备方法 | |
CN113648353A (zh) | 一种去腐生肌的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220429 |